Fosmidomycin, a specific inhibitor of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis

Tetrahedron Letters

Volumn 39, Issue 43, 1998, Pages 7913-7916

  Kuzuyama, Tomohisa ^a   Shimizu, Tomohiro ^a   Takahashi, Shunji ^a   Seto, Haruo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

2 C methylerythrose 4 phosphate; Fosmidomycin; Inhibitor; L Deoxy D xylulose 5 phosphate reductoisomerase

Indexed keywords

FOSMIDOMYCIN; ISOMERASE; MEVALONIC ACID; TERPENOID; XYLULOSE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CATALYSIS; CHLOROPLAST; ENZYME INHIBITION; ENZYME SPECIFICITY; GENE REARRANGEMENT; MOLECULAR CLONING;

EID: 0032558613     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)01755-9     Document Type: Article

References (28)

1. 1. Flesch G, Rohmer M. Eur. J. Biochem. 1988;175:405-411.
2. 2. Rohmer M, Knani M, Simonin P, Sutter B, Sahm H. Biochem. J. 1993;295:517-524.
3. 3. Lichtenthaler HK, Schwender J, Disch A, Rohmer M. Biochem. J. 1996;316:73-80.
4. 4. Seto H, Watanabe H, Furihata K. Tetrahedron Lett. 1996;37:7979-7982.
5. 5. Rohmer M, Seeman M, Horbach S, Bringer-Meyer S, Sahm H. J. Am. Chem. Soc. 1996;118:2564-2566.
6. 6. Duvold T, Bravo JM, Pale-Grosdemange C, Rohmer M. Tetrahedron Lett. 1997;38:4769-4772.
7. 7. Duvold T, Cali P, Bravo JM, Rohmer M. Tetrahedron Lett. 1997;38:6181-6184.
8. 8. Putra SR, Lois LM, Campos N, Boronat A, Rohmer M. Tetrahedron Lett. 1998;39:23-26.
9. 9. Orihara N, Furihata K, Seto H. J. Antibiot. 1997;50:979-981.
10. 10. Endler K, Schuricht U,. Henning L, Welzel P, Holst U, Aretz W, Bottger D, Huber G. Tetrahedron Lett. 1998;39:13-16.
11. 11. Li S.-M, Henning S, Heide L, Tetrahedron Lett. 1998;39:2717-2720.
12. 12. Orihara N, Kuzuyama T, Takahashi S, Furihata K, Seto H. J. Antibiot. 1998;51:676-678.
13. 13. Kuzuyama T, Takahashi S, Watanabe H, Seto H. Tetrahedron Lett. 1998;39:4509-4512.
14. 14. Takahashi S, Kuzuyama T, Watanabe H, Seto H. Proc. Natl. Acad. Sci. USA. in press.
15. 14 indicating that these organisms use the nonmevalonate pathway.
16. 28 indicating that a specific inhibitor of the nonmevalonate pathway does not show antibacterial activity against this genus including St. aureus.
17. 17. Iguchi E, Okuhara M, Kohsaka M, Aoki H, Imanaka H. J. Antibiot. 1980;33:18-23.
18. 18. Okuhara M, Kuroda Y, Goto T, Okamoto M, Terano H, Kohsaka M, Aoki H, Imanaka H. J. Antibiot. 1980;33:24-28.
19. 19. Kuroda Y, Okuhara M, Goto T, Okamoto M, Terano H, Kohsaka M, Aoki H, Imanaka H. J Antibiot. 1980;33:29-35.
20. 20. Shigi Y. J. Antimicrob. Chemoth. 1989;24:131-245.
21. 21. Kuzuyama T, Takahashi S, Shimizu T, Seto H. to be published elsewhere.
22. 22. One unit (U) of DXP reductoisomerase activity is defined as the amount of enzyme that causes the oxidation of 1 μmol of NADPH per min.
23. 7
24. 24. Kuzuyama T, Takahashi S, Seto H. to be published elsewhere.
25. 25. Hemmi K, Takeno H, Hashimoto M, Kamiya T. Chem. Pharm. Bull. 1982;30:111-118.
26. 26. SatyanarayanaT, Radhakrishnan AN. Biochim. Biophys. Acta. 1965;110:380-388.
27. 20
28. 28. Horbach S, Sahm H, Welle R. FEMS Microbiol. Lett. 1993;111:135-140.